Advertisement

PC-FACS November 2022

      Background: Cancer cachexia is a common, debilitating condition with limited therapeutic options.1-3 Can a novel, multimodal therapy improve cancer anorexia-cachexia syndrome (CACS) outcomes?
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pain and Symptom Management
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect